Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Cataract

Subspecialties Cataract

Clarity in Cataract Management

| Sponsored by Keeler

The Visiometrics HD Analyzer – for more personalized procedure selection and higher patient satisfaction

Subspecialties Cataract

Dousing the Post-Cataract Flames

| Rochelle Nataloni

Anti-inflammatories that reduce patient adherence or offer a more reliable delivery mechanism are driving the evolution of postoperative regimens

Subspecialties Cataract

Lifetimes of Innovation

| Sponsored by Bausch + Lomb

Bausch + Lomb reflects on a legacy of ophthalmic excellence – from the enVista® IOL platform to the Vitesse™ hypersonic vitrectomy system, and beyond

Subspecialties Cataract

Doubling Down on Virtual Surgery

| Harald P. Studer

Digital twin technology is enabling patient-specific surgery planning for optimal refractive outcomes

Subspecialties Refractive

The New Generation: Electronic IOLs

| Sponsored by SAV-IOL

Restoring vision using a smart, active intraocular lens for cataract surgery

Subspecialties Cataract

The Digitalization and Personalization of Eye Care

| Sponsored by Optimo Medical

Software that models the eye and simulates surgery on a digital twin is revolutionizing cataract treatment

Subspecialties Cataract

DEXYCU: Jason Bacharach

| Sponsored by EyePoint Pharmaceuticals

Jason Bacharach on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Subspecialties Cataract

DEXYCU: Mark Pyfer

| Sponsored by EyePoint Pharmaceuticals

Mark Pyfer on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Subspecialties Cataract

A NOD to Affirm Performance

| John Sparrow

The RCOphth National Ophthalmology Database (NOD) Audit can provide richer outcomes analysis than any single individual or institution – and cost less

Subspecialties Cataract

DEXYCU: Michael Savetsky

| Sponsored by EyePoint Pharmaceuticals

Michael Savetsky on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register